Companies: 49,246 Total Market Cap: 132591774254860.43

Invites Biocore

XKON-216400
Testing Laboratories
Rank #33215
Market Cap 28.50 M
Volume 43
Price 3.70
Change (%) 0.19%
Country or region South Korea South Korea

Invites Biocore's latest marketcap:

28.50 M

As of 05/20/2025, Invites Biocore's market capitalization has reached $28.50 M. According to our data, Invites Biocore is the 33215th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 28.50 M
Revenue (ttm) 0
Net Income (ttm) 0
Shares Out 7.71 M
EPS (ttm) 0
Forward PE 0.00
Ex-Dividend Date n/a
Earnings Date n/a
Market Cap Chart
Data Updated: 05/20/2025

Invites Biocore's yearly market capitalization.

Invites Biocore has seen its market value drop from ₩108.34 B to ₩40.02 B since 2020, representing a total decrease of 63.06% and an annual compound decline rate (CAGR) of 20.31%.
Date Market Cap Change (%)
05/20/2025 ₩40.02 B -3.88%
12/30/2024 ₩41.72 B -41.83%
12/28/2023 ₩71.72 B 29.71%
12/29/2022 ₩55.29 B -33.92%
12/30/2021 ₩83.67 B -22.78%
12/30/2020 ₩108.34 B

Company Profile

About Invites Biocore Co., Ltd.

Invites Biocore Co., Ltd. is a leading provider of bioanalytical and central lab services, operating in South Korea and internationally. Founded in 2001 and headquartered in Seoul, the company was formerly known as Biocore Co., Ltd. before rebranding in March 2021.

Core Services

  • Bioanalytical Testing: Includes biological equivalence tests, clinical trials, toxicokinetics, nonclinical trials, biomarker analysis, and comparative dissolution tests.
  • Clinical Services: Offers project strategic planning, medical translation, clinical research, quality assurance, monitoring, and data management.
  • Pharmaceutical Testing: Covers quality control, emergency food and drug safety testing, impurity testing, and stability testing for licensed pharmaceutical products.
  • Genetic & Diagnostic Services: Provides disease susceptibility testing, anticancer drug susceptibility tests, personalized genetic testing, chromosomal microarray analysis, newborn screening, and non-invasive prenatal testing.
  • Sequencing & Analysis: Delivers sequencing, microarray analysis, and Real-Time PCR analysis services.

Products

  • Real-Time PCR Kits
  • ApoE genotype analysis products
  • HLA-B*27 and HLA-B*51 genetic analysis products

Additional Offerings

The company also provides cold-chain and sample transport packaging, data logger devices, and logistics services to support research and clinical operations.

Frequently Asked Questions

As of 05/20/2025, Invites Biocore (including the parent company, if applicable) has an estimated market capitalization of $28.50 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

Invites Biocore global market capitalization ranking is approximately 33215 as of 05/20/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region South Korea
Founded 2001
IPO Date n/a
Employees n/a
CEO Hyung-Sik Choi
Sector
Industry Testing Laboratories
Address IT Future Tower
Seoul, 08511
South Korea
Website https://www.bio-core.com
People Also Watch
SHE-301508
4.49 0.19%
SHA-688334
2.32 0.19%
HCT
6.33 0.19%
SGXC-LMS
0.29 0.19%